People who are immunocompromised : know how to protect yourself and what to do if you get sick

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated June 29, 2022
  
  Some people who are immunocompromised (have a weakened immune system) are more likely to get sick with COVID-19 or be sick for a longer period. People are considered to be moderately or severely immunocompromised due to several types of conditions and treatments, including:
  
  • Active treatment for solid tumor and hematologic malignancies
  
  • Receipt of solid-organ transplant and taking immunosuppressive therapy
  
  • Receipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant (HCT) (within 2 years of transplantation or taking immunosuppressive therapy)
  
  • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  
  • Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3, history of an AIDS-defining illness without immune reconstitution, or clinical manifestations of symptomatic HIV)
  
  • Active treatment with high-dose corticosteroids (i.e., 20 or more mg of prednisone or equivalent per day when administered for 2 or more weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor necrosis factor (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory
  
  If you or someone you live or spend time with is immunocompromised, it is important to have a COVID-19 plan to protect yourself from infection and prepare for what to do if you get sick. Information on this page can help you build a COVID-19 plan for preventing, diagnosing, and treating COVID, so you know what to do and can act quickly if you’re exposed, develop symptoms, or test positive and when COVID-19 levels are increasing in your community.
  
  
• Subjects:
  Coronavirus Infections COVID-19 COVID-19 Vaccines Immunization, Secondary Immunocompromised Host Vaccination
• Document Type:
  Webpage
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:28f3488a192caca91cc3e4e174728ab5cfc3e403002d6c1ad58a140ea6f672b2
• Download URL:
  https://stacks.cdc.gov/view/cdc/118664/cdc_118664_DS1.pdf
• File Type:
  [PDF - 294.01 KB ]